CF33-hNIS-antiPDL1. *moves mouse to x button to close tab* “But wait!” your writer screams from the page, “I promise it’s interesting!” Whilst I may not have the teaching prowess of Ms Frizzle, I implore you to stick around, because Imugene’s (ASX: IMU) immuno-oncology stuff is really interesting once you wrap your head around it. The
Read More
If Doctor Google can diagnose your current ailments, medical informatics company Alcidion (ASX: ALC) may soon be predicting your future needs after being engaged by Healthscope to develop a data and analytics solution. The agreement, valued at $895,000 over three-years, will see the two companies work together as Healthscope seeks to transform the way healthcare
Read More